OpenURL Connection Search

Select item for more details and to access through your institution.

IMMUNOPHENOTYPIC CHARACTERIZATION OF RICHTER SYNDROME DIFFUSE LARGE B‐CELL LYMPHOMA TYPE AND COMPARISON WITH THE ORIGINAL CHRONIC LYMPHOCYTIC LEUKEMIA.
Published in:
Hematological Oncology, 2023, v. 41, p. 645, doi. 10.1002/hon.3165_495
By:
- Martin‐Moro, F.;
- Marquet‐Palomanes, J.;
- Piris‐Villaespesa, M.;
- Garcia‐Cosio, M.;
- Ballester, R.;
- Rodriguez‐Martin, E.;
- Moreno‐Jimenez, G.;
- Garcia‐Vela, J. A.;
- Roldan, E.;
- Lopez‐Jimenez, F. J.
Publication type:
Article
Comparison Between aaIPI, LAB‐PI, NCCN‐IPI and GELTAMO‐IPI to Predict Prognosis in Elderly Patients with Diffuse Large‐B Cell Lymphoma who Undergo R‐CHOP/R‐miniCHOP.
Published in:
Hematological Oncology, 2023, v. 41, p. 413, doi. 10.1002/hon.3164_304
By:
- Martin‐Moro, F.;
- Marquet‐Palomanes, J.;
- Bento, L.;
- Diaz‐Lopez, A.;
- Garcia‐Vela, J. A.;
- Sanchez‐Pina, J. M;
- Cordoba, R.;
- Salar, A.;
- Novelli, S.;
- Rodriguez‐Salazar, M. J.;
- Lario‐Arribas, A.;
- Gonzalez, S.;
- Del Campo, R.;
- Luzardo, H. D.;
- Garcia, D.;
- Abrisqueta, P.;
- Garcia‐Sancho, A. Martin;
- Sancho, J. M.;
- Gutierrez, A.;
- Lopez‐Jimenez, F. J.
Publication type:
Article
Bone Marrow Assessment may be Omitted in Newly Diagnosed Diffuse Large B‐Cell Lymphomas with Primary CNS Involvement.
Published in:
Hematological Oncology, 2023, v. 41, p. 403, doi. 10.1002/hon.3164_295
By:
- Martin‐Moro, F.;
- Lopez‐Pereira, P.;
- Marquet‐Palomanes, J.;
- Bento, L.;
- Salar, A.;
- Sancho, J. M.;
- Gonzalez‐Villambrosia, S.;
- Lario‐Arribas, A.;
- Sanchez‐Pina, J. M.;
- Garcia, D.;
- Queizan, J. A.;
- Garcia‐Sancho, A. Martin;
- Bastos‐Oreiro, M.;
- Lopez‐Jimenez, F. J.
Publication type:
Article
A SINGLE BLOOD TEST IS ABLE TO CLASSIFY DLBCL PATIENTS IN THREE PROGNOSTIC CLUSTERS AT DIAGNOSIS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.81_2880
By:
- Martín Moro, F.;
- Marquet Palomanes, J.;
- González Rodríguez, A.;
- Delgado Trillo, I.;
- López, C.;
- Herrera, F.;
- Villarrubia Espinosa, J.;
- Moreno Jiménez, G.;
- García Vela, J. A.;
- López Jiménez, F. J.
Publication type:
Article
FINDING A CONCORDANT OR DISCORDANT BONE MARROW INVOLVEMENT BY HISTOLOGY OR FLOW CYTOMETRY AT DLBCL NOS DIAGNOSIS IMPLIES A WORSE PROGNOSIS WHEREAS PET‐FDG DOES NOT.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.82_2880
By:
- Martín Moro, F.;
- Marquet Palomanes, J.;
- Delgado Trillo, I.;
- Piris Villaespesa, M.;
- López, C.;
- Herrera, F.;
- Rodríguez Martín, E.;
- Martínez Lorca, A.;
- García‐Cosío Piqueras, M.;
- Roldán Santiago, E.;
- García Marco, J. A.;
- López Jiménez, F. J.;
- García Vela, J. A.
Publication type:
Article

Found: 5

IMMUNOPHENOTYPIC CHARACTERIZATION OF RICHTER SYNDROME DIFFUSE LARGE B‐CELL LYMPHOMA TYPE AND COMPARISON WITH THE ORIGINAL CHRONIC LYMPHOCYTIC LEUKEMIA.

Comparison Between aaIPI, LAB‐PI, NCCN‐IPI and GELTAMO‐IPI to Predict Prognosis in Elderly Patients with Diffuse Large‐B Cell Lymphoma who Undergo R‐CHOP/R‐miniCHOP.

Bone Marrow Assessment may be Omitted in Newly Diagnosed Diffuse Large B‐Cell Lymphomas with Primary CNS Involvement.

A SINGLE BLOOD TEST IS ABLE TO CLASSIFY DLBCL PATIENTS IN THREE PROGNOSTIC CLUSTERS AT DIAGNOSIS.

FINDING A CONCORDANT OR DISCORDANT BONE MARROW INVOLVEMENT BY HISTOLOGY OR FLOW CYTOMETRY AT DLBCL NOS DIAGNOSIS IMPLIES A WORSE PROGNOSIS WHEREAS PET‐FDG DOES NOT.